PLoS ONE (Apr 2011)

IL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey.

  • Stéphanie Boisson-Dupuis,
  • Jamila El Baghdadi,
  • Nima Parvaneh,
  • Aziz Bousfiha,
  • Jacinta Bustamante,
  • Jacqueline Feinberg,
  • Arina Samarina,
  • Audrey V Grant,
  • Lucile Janniere,
  • Naima El Hafidi,
  • Amal Hassani,
  • Daniel Nolan,
  • Jilali Najib,
  • Yildiz Camcioglu,
  • Nevin Hatipoglu,
  • Cigdem Aydogmus,
  • Gonul Tanir,
  • Caner Aytekin,
  • Melike Keser,
  • Ayper Somer,
  • Guside Aksu,
  • Necil Kutukculer,
  • Davood Mansouri,
  • Alireza Mahdaviani,
  • Setareh Mamishi,
  • Alexandre Alcais,
  • Laurent Abel,
  • Jean-Laurent Casanova

DOI
https://doi.org/10.1371/journal.pone.0018524
Journal volume & issue
Vol. 6, no. 4
p. e18524

Abstract

Read online

In the last decade, autosomal recessive IL-12Rβ1 deficiency has been diagnosed in four children with severe tuberculosis from three unrelated families from Morocco, Spain, and Turkey, providing proof-of-principle that tuberculosis in otherwise healthy children may result from single-gene inborn errors of immunity. We aimed to estimate the fraction of children developing severe tuberculosis due to IL-12Rβ1 deficiency in areas endemic for tuberculosis and where parental consanguinity is common.We searched for IL12RB1 mutations in a series of 50 children from Iran, Morocco, and Turkey. All children had established severe pulmonary and/or disseminated tuberculosis requiring hospitalization and were otherwise normally resistant to weakly virulent BCG vaccines and environmental mycobacteria. In one child from Iran and another from Morocco, homozygosity for loss-of-function IL12RB1 alleles was documented, resulting in complete IL-12Rβ1 deficiency. Despite the small sample studied, our findings suggest that IL-12Rβ1 deficiency is not a very rare cause of pediatric tuberculosis in these countries, where it should be considered in selected children with severe disease.This finding may have important medical implications, as recombinant IFN-γ is an effective treatment for mycobacterial infections in IL-12Rβ1-deficient patients. It also provides additional support for the view that severe tuberculosis in childhood may result from a collection of single-gene inborn errors of immunity.